Francesca Taraballi , Anna Pastò , Guillermo Bauza , Catherine Varner , Alberto Amadori , Ennio Tasciotti
{"title":"Immunomodulatory potential of mesenchymal stem cell role in diseases and therapies: A bioengineering prospective","authors":"Francesca Taraballi , Anna Pastò , Guillermo Bauza , Catherine Varner , Alberto Amadori , Ennio Tasciotti","doi":"10.1016/j.regen.2019.100017","DOIUrl":null,"url":null,"abstract":"<div><p><span>Stem cell-based therapies are promising solutions to tackle several conditions. In particular, mesenchymal stem cells (MSCs) own very unique characteristics that have often been described as a “cure-all”. In addition to their differentiation capacity, MSCs have demonstrated both trophic and immunomodulatory suppression of inflammation. These properties have been exploited to develop cellular therapies for different inflammatory-related pathologies. In this review, we describe how to utilize the </span>immunosuppressive<span> potential of MSCs for regenerative purposes and cancer therapy. Moreover, we report innovative approaches from tissue engineering<span> and nanomedicine that demonstrate MSCs’ potential to improve their clinical translation.</span></span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"4 ","pages":"Article 100017"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regen.2019.100017","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunology and regenerative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468498818300507","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Stem cell-based therapies are promising solutions to tackle several conditions. In particular, mesenchymal stem cells (MSCs) own very unique characteristics that have often been described as a “cure-all”. In addition to their differentiation capacity, MSCs have demonstrated both trophic and immunomodulatory suppression of inflammation. These properties have been exploited to develop cellular therapies for different inflammatory-related pathologies. In this review, we describe how to utilize the immunosuppressive potential of MSCs for regenerative purposes and cancer therapy. Moreover, we report innovative approaches from tissue engineering and nanomedicine that demonstrate MSCs’ potential to improve their clinical translation.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
